1Kearney, PM, Whelton, M, Reynolds, K, et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217–223.
2Lewington, S, Clarke, R, Qizilbash, N, et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913.
3Hertog, MG, Feskens, EJ, Hollman, PC, et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007–1011.
4Geleijnse, JM, Launer, LJ, Van der Kuip, DA, et al. (2002) Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 75, 880–886.
5Knekt, P, Jarvinen, R, Reunanen, A, et al. (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 312, 478–481.
6Yochum, L, Kushi, LH, Meyer, K, et al. (1999) Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 149, 943–949.
7Xu, Y, Simon, JE, Welch, C, et al. (2011) Survey of polyphenol constituents in grapes and grape-derived products. J Agric Food Chem 59, 10586–10593.
8Preuss, HG, Wallerstedt, D, Talpur, N, et al. (2000) Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. J Med 31, 227–246.
9Castilla, P, Echarri, R, Davalos, A, et al. (2006) Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 84, 252–262.
10Clifton, PM (2004) Effect of grape seed extract and quercetin on cardiovascular and endothelial parameters in high-risk subjects. J Biomed Biotechnol 2004, 272–278.
11Stein, JH, Keevil, JG, Wiebe, DA, et al. (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100, 1050–1055.
12Chaves, AA, Joshi, MS, Coyle, CM, et al. (2009) Vasoprotective endothelial effects of a standardized grape product in humans. Vascul Pharmacol 50, 20–26.
13Hashimoto, M, Kim, S, Eto, M, et al. (2001) Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery. Am J Cardiol 88, 1457–1460, A9.
14Barona, J, Aristizabal, JC, Blesso, CN, et al. (2012) Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr 142, 1626–1632.
15Freedman, JE, Parker, C, Li, L, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792–2798.
16Keevil, JG, Osman, HE, Reed, JD, et al. (2000) Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 130, 53–56.
17Shenoy, SF, Keen, CL, Kalgaonkar, S, et al. (2007) Effects of grape seed extract consumption on platelet function in postmenopausal women. Thromb Res 121, 431–432.
18van Mierlo, LA, Zock, PL, van der Knaap, HC, et al. (2010) Grape polyphenols do not affect vascular function in healthy men. J Nutr 140, 1769–1773.
19Ward, NC, Hodgson, JM, Croft, KD, et al. (2005) The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J Hypertens 23, 427–434.
20Sano, A, Uchida, R, Saito, M, et al. (2007) Beneficial effects of grape seed extract on malondialdehyde-modified LDL. J Nutr Sci Vitaminol (Tokyo) 53, 174–182.
21Park, YK, Kim, JS & Kang, MH (2004) Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 22, 145–147.
22Sivaprakasapillai, B, Edirisinghe, I, Randolph, J, et al. (2009) Effect of grape seed extract on blood pressure in subjects with the metabolic syndrome. Metabolism 58, 1743–1746.
23Dohadwala, MM, Hamburg, NM, Holbrook, M, et al. (2010) Effects of Concord grape juice on ambulatory blood pressure in prehypertension and stage 1 hypertension. Am J Clin Nutr 92, 1052–1059.
24Ried, K, Sullivan, TR, Fakler, P, et al. (2012) Effect of cocoa on blood pressure. The Cochrane Database of Systematic Reviews 8, CD008893.
25Hodgson, JM, Puddey, IB, Woodman, RJ, et al. (2012) Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med 172, 186–188.
26Manach, C, Williamson, G, Morand, C, et al. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S–242S.
28Yanagisawa, M, Kurihara, H, Kimura, S, et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415.
29Dhaun, N, Goddard, J, Kohan, DE, et al. (2008) Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension 52, 452–459.
30Verma, S, Buchanan, MR & Anderson, TJ (2003) Endothelial function testing as a biomarker of vascular disease. Circulation 108, 2054–2059.
31Vallance, P, Leone, A, Calver, A, et al. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339, 572–575.
32Antithrombotic Trialists' Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324, 71–86.
34Edirisinghe, I, Burton-Freeman, B & Tissa, KC (2008) Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond) 114, 331–337.
35Siotia, A, Buckland, R, Judge, HM, et al. (2006) Utility of a whole blood single platelet counting assay to monitor the effects of tirofiban in patients with acute coronary syndromes scheduled for coronary intervention. Thromb Haemost 95, 997–1002.
36Scalbert, A & Williamson, G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S–2085S.
37Feringa, HH, Laskey, DA, Dickson, JE, et al. (2011) The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc 111, 1173–1181.
38Gordon, RD, Wolfe, LK, Island, DP, et al. (1966) A diurnal rhythm in plasma renin activity in man. J Clin Invest 45, 1587–1592.
39Linsell, CR, Lightman, SL, Mullen, PE, et al. (1985) Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 60, 1210–1215.
40Snoep, JD, Hovens, MM, Pasha, SM, et al. (2009) Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines. Hypertension 54, 1136–1142.
41Ralay, RH, Diebolt, M & Andriantsitohaina, R (2004) Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide. Br J Pharmacol 142, 671–678.
42Feng, Z, Wei, RB, Hong, Q, et al. (2010) Grape seed extract enhances eNOS expression and NO production through regulating calcium-mediated AKT phosphorylation in H2O2-treated endothelium. Cell Biol Int 34, 1055–1061.
43Khan, NQ, Lees, DM, Douthwaite, JA, et al. (2002) Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (Lond) 103, Suppl. 48, 72S–75S.
44Luscher, TF & Barton, M (2000) Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102, 2434–2440.
45Loke, WM, Hodgson, JM, Proudfoot, JM, et al. (2008) Pure dietary flavonoids quercetin and ( − )-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88, 1018–1025.
46Tang, WJ, Hu, CP, Chen, MF, et al. (2006) Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol 84, 163–171.
47Xiao, HB, Jun, F, Lu, XY, et al. (2009) Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level. Eur J Pharmacol 616, 213–222.